PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2395.97%
Both yoy net incomes decline, with 1097.HK at -3.75%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
56.25%
D&A growth well above 1097.HK's 80.07%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-479.06%
Negative yoy deferred tax while 1097.HK stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
181.45%
Slight usage while 1097.HK is negative at -72.02%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
100.00%
AR growth well above 1097.HK's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
60.35%
Some inventory rise while 1097.HK is negative at -112.15%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
100.00%
AP growth of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
331.42%
Some yoy usage while 1097.HK is negative at -476.30%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
207.57%
Well above 1097.HK's 310.88%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
27.59%
Some CFO growth while 1097.HK is negative at -243.77%. John Neff would note a short-term liquidity lead over the competitor.
8.21%
CapEx growth well above 1097.HK's 11.40%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
100.00%
Acquisition growth of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-300.00%
Negative yoy purchasing while 1097.HK stands at 50.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-52.47%
We reduce yoy sales while 1097.HK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-94.80%
We reduce yoy other investing while 1097.HK is 1.60%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-107.66%
We reduce yoy invests while 1097.HK stands at 9.41%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
86.79%
We repay more while 1097.HK is negative at -657.33%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
23.54%
Lower share issuance yoy vs. 1097.HK's 82.00%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.